
Mirugen – Unlocking the Power of Retina Regeneration
Mirugen – Unlocking the Power of Retina Regeneration
Search results
Mirugen – Unlocking the Power of Retina Regeneration
Retina UK is delighted that the Scottish Medicines Consortium (SMC) has accepted the gene therapy Luxturna (voretigene neparvovec) for ongoing use by the NHS in Scotland.
After more than 10 years of service as Chair of the Board of Trustees, Don Grocott has retired.
Next month, Anisha and Sheena will take on The Thames Path Challenge. Together, they explain why they decided to join #TeamRetinaUK.
Whether you're an expert runner, or a rebel *with* a cause, there's no better experience than the London Marathon!
Have you ever been tempted to take part in the TCS London Marathon? In 2022 the TCS London Marathon raised £58.3 million for charity so it’s a vital source of income.
This page explains the different types of genetic tests: diagnostic testing, predictive testing, carrier testing and research testing
Autoimmune diseases are quite distinct from inherited retinal dystrophies.
In recent years there has, understandably, been a lot of excitement around cutting-edge therapies that target the specific genetic faults underlying inherited sight loss.
We are joined today by Tina Garvey, Chief Execute Officer at Retina UK.